3
H index
0
i10 index
19
Citations
Christopher James Sampson : Citation Profile
Office of Health Economics | RESEARCH PRODUCTION: 6 Articles 14 Papers RESEARCH ACTIVITY:
EXPERT IN:
MORE DETAILS IN: ABOUT THIS REPORT:
|
9 years (2013 - 2022). 
Relations with other researchers
Works with:
Authors registered in RePEc who have co-authored more than one work in the last five years with Christopher James Sampson. | Is cited by:
| Cites to:
|
Main data
Where Christopher James Sampson has published?
| Journals with more than one article published | # docs |
|---|---|
| PharmacoEconomics - Open | 2 |
| Working Papers Series with more than one paper published | # docs |
|---|---|
| Contract Research / Office of Health Economics | 3 |
| MPRA Paper / University Library of Munich, Germany | 3 |
| Grant-Funded Research / Office of Health Economics | 2 |
| Briefing / Office of Health Economics | 2 |
Recent works citing Christopher James Sampson (2024 and 2023)
| Year | Title of citing document |
|---|
Works by Christopher James Sampson:
| Year | Title | Type | Cited |
|---|---|---|---|
| 2019 | How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy In: Briefing. [Full Text][Citation analysis] | paper | 3 |
| 2021 | How is Quality of Life Measured for Health Technology Assessments? In: Briefing. [Full Text][Citation analysis] | paper | 0 |
| 2018 | Barriers to Uptake of Minimal Access Surgery in the United Kingdom In: Consulting Report. [Full Text][Citation analysis] | paper | 2 |
| 2018 | The Impact of New Medicines in the NHS: 70 Years of Innovation In: Consulting Report. [Full Text][Citation analysis] | paper | 0 |
| In: . [Full Text][Citation analysis] | paper | 0 | |
| In: . [Full Text][Citation analysis] | paper | 0 | |
| In: . [Full Text][Citation analysis] | paper | 0 | |
| In: . [Full Text][Citation analysis] | paper | 0 | |
| In: . [Full Text][Citation analysis] | paper | 0 | |
| 2018 | R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C In: Research Paper. [Full Text][Citation analysis] | paper | 4 |
| 2020 | Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? In: Research Paper. [Full Text][Citation analysis] | paper | 2 |
| 2013 | Cost implications of treatment non-completion in a forensic personality disorder service In: MPRA Paper. [Full Text][Citation analysis] | paper | 0 |
| 2013 | Happy and healthy: a joint model of health and life satisfaction In: MPRA Paper. [Full Text][Citation analysis] | paper | 0 |
| 2013 | The relationship between individual risk and cost-effectiveness in screening interventions In: MPRA Paper. [Full Text][Citation analysis] | paper | 0 |
| 2021 | Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al. In: Medical Decision Making. [Full Text][Citation analysis] | article | 1 |
| 2022 | Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy In: Applied Health Economics and Health Policy. [Full Text][Citation analysis] | article | 0 |
| 2013 | Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 In: The European Journal of Health Economics. [Full Text][Citation analysis] | article | 0 |
| 2019 | Transparency in Decision Modelling: What, Why, Who and How? In: PharmacoEconomics. [Full Text][Citation analysis] | article | 3 |
| 2017 | Model Registration: A Call to Action In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 4 |
| 2022 | NICE and the EQ-5D-5L: Ten Years Trouble In: PharmacoEconomics - Open. [Full Text][Citation analysis] | article | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 10 2023. Contact: CitEc Team